G7U-20418-77494 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-28
Registered in v-safe
2020-12-28
Dose 1 — Pfizer-BioNTech
2020-12-28
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · Muscle or body aches

Adult check-in
2020-12-29
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Muscle or body aches · Be unable to do your normal daily activities

Adult check-in
2020-12-29
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2020-12-30
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-31
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-02
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-13
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-19
Dose 2 — Pfizer-BioNTech
2021-01-20
Survey response — days 1–6 daily, dose 2
MedDRA: Cough — Feeling: Good · Site: Pain · Joint pains · Be unable to do your normal daily activities

Free text: Cough

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-21
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-23
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-24
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-18
Survey response — day 28, dose 2
MedDRA: Condition aggravated, Migraine, Pre-existing disease — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Large increase in number of and severity of migraines

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-18
Report sent to call center — day 28, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-05
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-29
Call 1 — Left Voicemail
2021-09-24
Dose 3 — Pfizer-BioNTech
2021-09-29
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-07
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-28	Pfizer-BioNTech
2	2021-01-19	Pfizer-BioNTech
3	2021-09-24	Pfizer-BioNTech	No

Call center

2 call center cases

1 unsuccessful · 1 priority 2/3 (triaged and no follow up)

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-20

Systemic reaction (other): Cough

Release 4 — day 28, dose 2

2021-02-18

Symptoms: Large increase in number of and severity of migraines

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Condition aggravated	✓	✓	✓
SD	Migraine	✓	✓	✓
SD	Pre-existing disease	✓	✓	✓
SRO	Cough	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release